EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 27-Oct-2026 20:16 ET (28-Oct-2026 00:16 GMT/UTC)

HKU School of Computing and Data Science research team develops ClairS, achieving high-accuracy cancer mutation detection across multiple cancer types

The University of Hong Kong
Peer-Reviewed Publication

A research team led by Professor Ruibang LUO, Assistant Director (Learning Experience & Student Enrichment) and Associate Head of the Department of AI & Data Science, School of Computing and Data Science (CDS), The University of Hong Kong (HKU), has developed ClairS—a novel deep-learning algorithm that significantly improves the detection of cancer mutations using long-read sequencing. Tested on breast cancer, lung cancer and melanoma cell-line datasets, ClairS has demonstrated exceptional accuracy across various cancer types and sequencing conditions.

Journal: Nature Methods

HKUMed discovers new glioblastoma targets through landmark brain cancer research with Hong Kong Genome Institute

The University of Hong Kong
Peer-Reviewed Publication

Researchers from the Clinical Neuroscience Consortium (CNC), a collaborative platform jointly established by the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and Queen Mary Hospital, in collaboration with the Hong Kong Genome Institute (HKGI), have achieved a major breakthrough in brain cancer research by developing the most comprehensive map to date of isoform diversity in glioblastoma, the most common and aggressive form of brain cancer in adults. Using advanced long-read single-cell sequencing, the team uncovered thousands of previously unknown tumour-specific genetic isoforms that had remained invisible to conventional approaches. The discovery reveals a new source of potential therapeutic targets, including candidates that could be harnessed for future personalised cancer vaccines and immunotherapies. The findings were published in Nature Communications.

Journal: Nature Communications

Erectile dysfunction drug used to treat enlarged prostate symptoms may raise glaucoma risk

BMJ Group
Peer-Reviewed Publication

An erectile dysfunction drug that is also used to treat symptoms like sudden urgency and frequency, which are associated with an enlarged prostate in men, may heighten the risk of the serious eye condition, glaucoma, finds a large comparative study published online in the British Journal of Ophthalmology.

Journal: British Journal of Ophthalmology

$3.2 million NIH grant funds USC study of age-related inflammation and cancer

Keck School of Medicine of USC
Grant and Award Announcement

USC researchers have received a five-year NIH grant of up to $3.2 million to investigate how the hormone thymulin regulates age-related inflammation, or inflammaging, and whether it can improve responses to cancer immunotherapy. Building on earlier findings that thymulin helps suppress chronic inflammation and may enhance treatment effectiveness in older mice, the team will study its molecular mechanisms and therapeutic potential in aged mouse models of breast cancer and melanoma, as well as in human cells. The project aims to clarify how aging alters the immune system and to identify new strategies that could help older patients respond better to immunotherapy and potentially combat metastatic cancer.

Ontario Institute for Cancer Research welcomes Dr. Aaron Schimmer as president and scientific director

Ontario Institute for Cancer Research
Business Announcement

Dr. Aaron Schimmer officially steps into his role as President and Scientific Director of the Ontario Institute for Cancer Research (OICR) today, marking a new chapter for cancer research in the province.

Schimmer brings a wealth of scientific, clinical, strategic and operational expertise to lead OICR. An internationally recognized hematologist, blood cancer scientist and research leader, he most recently served as Director of Research at University Health Network’s (UHN) Princess Margaret Cancer Centre, where he is also a longtime clinician-scientist.

As President and Scientific Director of OICR, Schimmer will lead the Institute and deliver on OICR’s provincial mandate to accelerate cancer research in Ontario for better health and a stronger economy.

Researchers discover how tumors enlist nerves to keep growing

University of Oklahoma
Peer-Reviewed Publication

New research from the University of Oklahoma demonstrates how an aggressive form of breast cancer co-opts the body’s own immune system to attract nerves that fuel tumor growth.

Journal: Cell Death and Differentiation

Racial differences in sonographic evaluation in suspected cases of endometrial neoplasia

JAMA Network
Peer-Reviewed Publication

About the Study: In this cohort study of a diverse population of women, ultrasound completion rates were lower among Black women, primarily due to fibroids impairing endometrial visibility. Nevertheless, transvaginal sonography demonstrated a 76% completion rate and retained excellent ability to exclude cancer in Black women, regardless of fibroid presence.

Journal: JAMA Network Open

UI Health ophthalmology program ranks among nation's best in U.S. News report

University of Illinois Chicago
Business Announcement

U.S. News listed the ophthalmology program at UI Health at No. 16 in the nation and the hospital’s cancer care at No. 5 in Illinois and No. 5 in Chicago.

Molecular profiling reveals favorable risk pattern in rare aggressive uterine cancer

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — August 4, 2026 — A new case report was published in Volume 13 of Oncoscience on July 29, 2026, titled “Endometrial carcinosarcoma with multi-classifier molecular signature (MMRd-p53abn): A case report.”

Journal: Oncoscience

A promising solution to a cancer drug resistance problem

Weill Cornell Medicine
Peer-Reviewed Publication

A protein that can dial down oxidative stress in cells helps some cancers resist treatment with a widely used class of drugs called BTK inhibitors, according to a study led by investigators at Weill Cornell Medicine. The discovery points to a possible solution to the problem of BTK inhibitor treatment resistance.

Journal: Nature Communications

97
98
99
100
101